Home diagnostics Conduit is building a saliva-based at-home diagnostic test with a rapid one-hour result, presenting an opportunity to target consumer health monitoring, telemedicine platforms, and at-home testing retailers seeking scalable, user-friendly solutions.

MIT-backed credibility As a MIT-based biotech startup focusing on quantum computing for problem-solving, Conduit can leverage credibility to engage research institutions, grant programs, and high-value corporate partners seeking cutting-edge biomedical tech and verification capabilities.

Growing team With a small team (11-50 employees) in Cambridge, there is potential for flexible partnerships, contract research, and pilot programs to accelerate product development, regulatory readiness, and early adoption with limited organizational risk.

Revenue range Current revenue is in the modest seven-figure range, indicating room for scalable partnerships, channel deals, and enterprise collaborations that can accelerate go-to-market through integrated platforms and bulk testing solutions.

Tech compatibility The diverse tech stack and focus on rapid diagnostic delivery suggest opportunities to bundle with digital health platforms, data analytics partners, and consumer fintech integrations for seamless payments and user experiences.